Company / Operating Income
NEUROONE MEDICAL TECHNOLOGIES Corp Operating Income History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$11.9M
FY2025
5-year range
-$12.0M / -$4.9M
FY2021-FY2025
Trend
+0.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 8 years, ranging from -$12M in FY2024 to -$25,093 in FY2014.
Based on SEC 10-K filings.
-$12M in FY2025.
Declined from -$10M to -$12M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 0.6% year-over-year.
- Peak operating income was recorded in FY2014.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$11.9M | +0.6% |
| FY2024 | -$12.0M | -19.2% |
| FY2023 | -$10.0M | +1.8% |
| FY2022 | -$10.2M | -108.4% |
| FY2021 | -$4.9M | -15757.2% |
| FY2016 | -$30.9K | +13.9% |
| FY2015 | -$35.9K | -43.1% |
| FY2014 | -$25.1K | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026